DUBLIN--(BUSINESS WIRE)--The "Epiomic Epidemioloy Series: Refractive Errors Forecast in 18 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.
The main role of the optical components of the eye is focusing rays of light on the retina. The situation in which parallel rays are focused properly is known as emmetropia. Various defects caused by the inability of the eye to converge the refracted rays on the retina are known as refractive errors (ametropias).
This report covers the features and epidemiology facts of hyperopia, myopia and presbyopia. The report provides the current prevalent population for refractive errors across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.
In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the author's analysis team, several features of refractive errors patients, as well as the main comorbidities of the covered conditions have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of refractive errors include:
- Eye strain
- Diabetes mellitus
Key Topics Covered:
- Cause Of The Disease
- Risk Factors & Prevention
- Diagnosis Of The Disease
- Variation By Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With The Disease
- Methodology For Quantification Of Patient Numbers
- Top-Line Prevalence For Refractive Errors
- Features Of Refractive Error Patients
- Abbreviations Used In The Report
- Other Services & Solutions
- Reports & Publications
- Online Epidemiology Databases
- Online Pharmaceutical Pricing Database
For more information about this report visit https://www.researchandmarkets.com/research/wtts3m/epiomic?w=4